Myokardia Inc.

Myokardia Inc. focuses on clinical research in hypertrophic cardiomyopathy, with particular attention to symptomatic obstructive hypertrophic cardiomyopathy and left ventricular outflow tract obstruction. The funded studies examine cardiac symptoms, physical limitation, and exercise capacity in affected adults.

• Symptomatic obstructive hypertrophic cardiomyopathy
• Left ventricular outflow tract obstruction
• Patient-reported health status
• Exercise capacity

Research activity also includes imaging-based evaluation of cardiac structure and myocardial thickness in relation to disease burden.